Prosecution Insights
Last updated: April 19, 2026

Primoris Therapeutics Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18265110 METHOD FOR PREPARING HIGH-CONCENTRATION STEM CELL EXOSOMES WITH ENHANCED ANTI-INFLAMMATORY AND REGENERATIVE FUNCTIONS USING LIPOPOLYSACCHARIDE AND LIPOTEICHOIC ACID STEVENS, MARK V 1613 Non-Final OA Jun 02, 2023
17916340 METHOD FOR PREPARING CULTURE MEDIUM CONTAINING HIGH LEVELS OF HIGH-POTENCY EXOSOMES SECRETED BY CORD BLOOD STEM CELLS, AND USE THEREOF PAULUS, ERIN VIRGINIA 1631 Non-Final OA Sep 30, 2022

Managing Primoris Therapeutics Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month